罗伯特·清崎称美国财政部扩大债券回购计划为“量化宽松”并支持比特币

cryptonews.ruPublished on 2026-08-23Last updated on 2026-08-23

Abstract

罗伯特·清崎将美国财政部扩大国债回购计划称为“量化宽松”,并再次推荐比特币作为应对通胀的工具。他在8月22日的帖子中称此举为“印刷更多假美元”,并警告通胀将加剧,储蓄现金者将损失购买力。他建议投资者转向比特币、黄金、白银及特定房产等稀缺资产。 美国财政部于8月19日宣布,为支持市场流动性,将把10-20年期和20-30年期国债的回购操作规模从每次20亿美元至少翻倍至40亿美元。清崎将此政策直接与美联储的量化宽松相类比,尽管两者由不同机构执行且目的不同:财政部回购使用现有资金或发债收入,不直接新增货币;而量化宽松是央行的货币政策工具。 清崎还引用美元指数下跌作为通胀即将飙升的证据。不过,美元指数衡量的是美元兑一篮子外币的汇率,而非美国国内购买力。他重申其长期观点,即美国巨额债务和货币贬值威胁传统储蓄,强调金融教育的重要性,认为受过教育的投资者能通过投资增值资产变得更富有。 此前,清崎曾预测金价将达1万美元、银价200美元,并称白银是其8月首选。尽管比特币、黄金和白银价格波动剧烈,他仍将这些资产视为对冲通胀和金融体系风险的核心手段。

对美元的重新担忧促使《富爸爸穷爸爸》作者罗伯特·清崎在将扩大国债回购计划描述为量化宽松后,建议投资于稀缺资产。在8月22日于X平台发布的帖子中,他将政策变化与通胀风险联系起来,并呼吁粉丝们优先考虑比特币、黄金、白银和一些房地产。“他们正在印刷更多假美元,”清崎评论道。

财政部的决定旨在支持流动性,增加了对10至20年期和20至30年期名义证券的回购操作规模。在8月19日关于扩大长期证券回购规模的声明中,财政部将每次操作的规模从20亿美元增加到至少40亿美元;该决定自9月9日起生效,至11月4日止。清崎表示:

“美国财政部宣布了新一轮QE(量化宽松),换句话说,就是印刷假美元。”

在该声明发布之前,长期债券收益率曾大幅飙升:8月18日,30年期国债收益率达到5.34%,为19年来的最高水平。在财政部宣布扩大操作规模后,30年期债券收益率降至5.184%。

尽管两项计划都涉及政府证券,但国债回购和量化宽松由不同机构实施,且公开宣称的目标不同。财政部利用发行债务所得收入以及其普通基金中已有的现金来为回购提供资金,因此是用一种证券替换另一种证券,而非有新的货币进入流通。

相比之下,量化宽松是中央银行作为货币政策工具使用的大规模资产购买。财政部自身的行动并非美联储的量化宽松计划。

美元下跌支撑了清崎的通胀警告

清崎还以美元指数下跌作为证据,声称通胀将加速,持有现金的储蓄者将损失购买力。他说:“DXY(美元购买力指数)正在暴跌,这意味着通胀飙升……这意味着储蓄者持有的‘假’美元将成为最大的输家。”他的措辞反映的是他的评估,而非对消费者通胀的直接衡量。

DXY衡量的是美元对六种外币的汇率,其中欧元权重最大,它并不直接跟踪美元在美国国内能购买什么。财政部的声明重新引发了关于“贬值交易”的讨论,即美元走弱,而稀缺资产价格上涨。然而,DXY下跌并不会自动导致消费者价格的相应上涨。

这位专注于金融主题的作者将教育与识别能在通胀时期保值或增值的资产能力联系起来。《富爸爸穷爸爸》的作者给出了以下建议:

“事实是,受过教育的投资者投资于正在升值的资产,如黄金、白银、比特币和一些房地产,会变得更富有……而那些没有金融教育、投资于‘假’资产的人会变得更穷。”

在清崎发出警告之前,联邦债务就已超过40万亿美元,这为他对借贷的担忧增添了背景。根据美国财政部“Debt to the Penny”的数据,截至8月20日,未偿还公共债务总额约为40.03万亿美元,包括由公众持有的32.28万亿美元和政府内部债务7.75万亿美元。

几天前,清崎曾关注了黄金价格将达到1万美元、白银价格将达到200美元的预测,并将白银称为他八月份的首选。

比特币和黄金仍是其策略的核心

在他最新的帖子中,清崎重申了他长期以来的观点,即政府债务、货币贬值和通胀威胁着传统储蓄。7月,他曾警告说,全球经济衰退可能击垮许多人,而那些为重大市场动荡做好准备的人将受益。这个更笼统的崩盘警告将金融不稳定与美国债务和债券疲软联系起来,尽管他将美国经济描述为“破产”属于个人评估。

尽管这三种资产都存在显著的波动性,但比特币仍然是清崎偏好的抵御这些风险方式的核心,与黄金和白银并列。他在早前发出通胀警告时对比特币的乐观展望,将政府债务增加和潜在货币供应增长与法定货币的疲软联系起来。这些条件并不能保证任何特定资产都会升值或保持购买力。

作者在8月22日的帖子结尾,回到了金融教育的主题,并辩称最大的代价并非花在学习投资上的时间或金钱,而是当人们无法识别财务机会时所错过的潜在利润。

end-content

Trending Cryptos

Related Questions

Q罗伯特·清崎如何看待美国财政部扩大国债回购计划?

A罗伯特·清崎将美国财政部扩大长期国债回购计划称为新一轮的“量化宽松”,并认为这意味着正在印制更多的“假美元”。他担忧这会加剧通货膨胀风险。

Q根据文章,美国财政部扩大国债回购计划与美联储的量化宽松(QE)有何区别?

A美国财政部的国债回购计划旨在支持市场流动性,使用财政部现有资金或通过发行新债务来置换不同期限的国债,并未直接向经济体系注入新的货币。而量化宽松是中央银行为执行货币政策而进行的大规模资产购买,直接向市场注入基础货币。文章明确指出,财政部的行动本身并非美联储的量化宽松计划。

Q罗伯特·清崎建议投资者关注哪些资产来应对潜在的通货膨胀?

A罗伯特·清崎建议投资者关注比特币、黄金、白银以及某些房地产等稀缺资产,他认为这些资产在通货膨胀时期能够保值甚至增值。

Q文章中提到罗伯特·清崎引用了哪个指数来支持其对通胀加速的看法?

A罗伯特·清崎引用了美元指数(DXY)的下跌来支持他认为通货膨胀将加剧的看法。他认为DXY下跌意味着通胀将高涨。但文章也指出,DXY主要衡量美元对一篮子外币的汇率,并不直接等同于衡量美国国内的消费者通胀水平。

Q罗伯特·清崎为什么强调金融教育的重要性?

A罗伯特·清崎认为金融教育至关重要,因为受过教育的投资者能够识别在通胀时期可能保值增值的资产(如黄金、比特币),而缺乏金融教育的人可能会投资于所谓的“虚假”资产而变穷。他强调,最大的成本不是花在学习和投资上的时间和金钱,而是因无法识别金融机会而错失的潜在收益。

Related Reads

Three Months After the Passing of Little Dog Rosie, Her Medical Records Transformed into an AI Healthcare Company

Three months after the passing of his dog Rosie, AI entrepreneur Paul S. Conyngham secured $4 million in seed funding from Founders Fund for his new startup, Gamgee. The company aims to industrialize the experimental, AI-assisted process he pioneered to create a personalized mRNA cancer vaccine for Rosie, who suffered from mast cell tumors. With no formal biology background, Conyngham used AI tools like ChatGPT and AlphaFold to analyze Rosie's tumor DNA, identify target neoantigens, and design a custom mRNA vaccine sequence. Laboratory partners at UNSW produced the vaccine. Initial treatment showed tumor reduction, but Rosie's cancer later recurred and she was euthanized. Gamgee's goal is to streamline this "N-of-1" approach into a repeatable service for canine cancer patients, handling sequencing, vaccine design, production, and delivery. Clinical trials are planned in Australia in collaboration with research institutions. The company also eyes a longer-term vision of establishing personalized, mRNA-based medicine across species. The story highlights the broader challenge in personalized cancer treatment: compressing the entire timeline from design and regulatory approval to manufacturing and administration to match the patient's prognosis. While AI can accelerate target discovery, the remaining logistical and regulatory hurdles are significant. The article concludes by emphasizing that, for now, consulting qualified veterinary oncologists remains the responsible path for pet owners.

marsbit5m ago

Three Months After the Passing of Little Dog Rosie, Her Medical Records Transformed into an AI Healthcare Company

marsbit5m ago

mRNA Vaccine Too Slow, Dog Owner Loses Beloved Pet, World's First AI-Customized Dog Cancer Vaccine Arrives

A heartbreaking story from Australia showcases the intersection of AI, love, and loss. Paul Conyngham, an AI expert, lost his beloved bull terrier Rosie to cancer in 2024. Refusing to accept her prognosis, he used his machine learning skills, ChatGPT, and AlphaFold to design a personalized mRNA vaccine targeting her specific cancer mutations. The first vaccine dose, synthesized with help from university scientists, shrank Rosie's tumor by 75%, granting her a temporary reprieve. However, the cancer recurred with new mutations, requiring a second, updated vaccine. The traditional, slow production process couldn't deliver it in time, and Rosie passed away. Determined to prevent similar tragedies, Paul founded Gamgee, a startup named after a "Lord of the Rings" character. Backed by $4 million in seed funding from Founders Fund, Y Combinator, and others, Gamgee aims to industrialize and democratize personalized canine cancer vaccines. Their vision is an end-to-end platform where veterinarians submit tumor samples, AI algorithms rapidly identify target mutations, and customized mRNA vaccines are produced. The goal is to slash the design time to 48 hours and the total cost to around $2,000 per treatment. The addressable market is vast, with about 6 million dogs diagnosed with cancer annually in the US alone. Beyond pets, Gamgee's "N-of-1" medicine approach, validated in dogs, paves the way for similar ultra-personalized cancer therapies for humans, a field recently energized by Moderna's successful AI-designed mRNA vaccine trial for melanoma. Rosie's legacy lives on, fueling a mission to turn personalized hope into scalable, timely reality for millions.

marsbit9m ago

mRNA Vaccine Too Slow, Dog Owner Loses Beloved Pet, World's First AI-Customized Dog Cancer Vaccine Arrives

marsbit9m ago

Not Being a Follower of Silicon Valley: A Few Young PhD Students Bet on the Integrated Brain of Bipedal Humanoid Robots

This article profiles GongShengZhiXing, a startup founded by 1996-born Ding Pengxiang with a core team of Ph.D. students, all in their twenties. They are developing an end-to-end, integrated "brain" (base model) for bipedal humanoid robots, focusing on full-body dynamic coordination rather than the industry's more common modular, layered approach. The team's stance is that for humanoids to integrate into human environments, an end-to-end model—where a single system handles perception, decision-making, and control directly—is ultimately more efficient and scalable than layered architectures that separate high-level "brain" and low-level "cerebellum" functions. They argue layered systems create information bottlenecks. A key demo shows their robot driving a go-kart at high speed, demonstrating synchronized hand-eye-foot coordination and multi-contact balance—a complex task highlighting their focus on whole-body dynamics over simple kinematics. Technically, their model outputs commands at the joint level and incorporates a "Motion Expert" module and techniques like DriftDistill to simultaneously learn task completion and physical stability from data. Acknowledging challenges like severe data scarcity for full-body mobile manipulation, they employ methods like TrajBooster to synthesize training data. Ding Pengxiang believes true "emergence" of new skills at the joint-movement level is the goal, but commercial viability likely requires scaling to millions of training hours. The team aims not to follow Silicon Valley trends but to pioneer and potentially set global standards in this nascent, unconverged field of embodied AI.

marsbit10m ago

Not Being a Follower of Silicon Valley: A Few Young PhD Students Bet on the Integrated Brain of Bipedal Humanoid Robots

marsbit10m ago

Trading

Spot

Hot Articles

Discussions

Welcome to the HTX Community. Here, you can stay informed about the latest platform developments and gain access to professional market insights. Users' opinions on the price of S (S) are presented below.

活动图片